BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6327446)

  • 1. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit.
    Maiorino RM; Aposhian HV
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):240-50. PubMed ID: 2983455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid.
    Aposhian HV
    Adv Enzyme Regul; 1982; 20():301-19. PubMed ID: 6287818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three antidotes on arsenic toxicity in the common earthworm (Lumbricus terrestris).
    Li W; Chien PK; Furst A
    J Appl Toxicol; 1994; 14(3):181-3. PubMed ID: 7521893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
    Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
    Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DL- and meso-dimercaptosuccinic acid: in vitro and in vivo studies with sodium arsenite.
    Aposhian HV; Hsu CA; Hoover TD
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):206-13. PubMed ID: 6306868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of various dithiol compounds in acute As2O3 poisoning in mice.
    Kreppel H; Reichl FX; Szinicz L; Fichtl B; Forth W
    Arch Toxicol; 1990; 64(5):387-92. PubMed ID: 2169719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
    Domingo JL; Bosque MA; Llobet JM; Corbella J
    Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.
    Inns RH; Rice P; Bright JE; Marrs TC
    Hum Exp Toxicol; 1990 Jul; 9(4):215-20. PubMed ID: 2167707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
    Hsu CA; Aposhian HV; Heydolph S; Parr W
    J Pharmacol Exp Ther; 1983 Feb; 224(2):314-8. PubMed ID: 6687396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of various antidotes on the biliary and intestinal excretion of arsenic in situ and into the feces in vivo in guinea-pigs after injection of As2O3.
    Reichl FX; Kreppel H; Szinicz L; Mückter H; Fichtl B; Forth W
    Arch Toxicol; 1994; 69(1):35-8. PubMed ID: 7536408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated rat kidney tubules as a screening system for arsenic antidotes.
    Mückter H; Islambouli S; Doklea E; Hopfer C; Szinicz L; Fichtl B; Forth W
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):118-28. PubMed ID: 8393218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic Toxicity: Molecular Targets and Therapeutic Agents.
    Nurchi VM; Djordjevic AB; Crisponi G; Alexander J; Bjørklund G; Aaseth J
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033229
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits.
    Inns RH; Rice P
    Hum Exp Toxicol; 1993 May; 12(3):241-6. PubMed ID: 8100435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue decorporation of polonium-210 in rats by DMPA.
    Aposhian HV; Dart RC; Aposhian MM; Dawson BV
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):157-71. PubMed ID: 2827276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral treatment with Bal, DMPS or DMSA arsenic in organs of mice injected with arsenic trioxide.
    Schäfer B; Kreppel H; Reichl FX; Fichtl B; Forth W
    Arch Toxicol Suppl; 1991; 14():228-30. PubMed ID: 1666826
    [No Abstract]   [Full Text] [Related]  

  • 18. Arsenic excretion after treatment of arsenic poisoning with DMSA or DMPS in mice.
    Maehashi H; Murata Y
    Jpn J Pharmacol; 1986 Jan; 40(1):188-90. PubMed ID: 3007828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(2,3-dimercaptopropyl)phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication.
    Stine ER; Hsu CA; Hoover TD; Aposhian HV; Carter DE
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):329-36. PubMed ID: 6474464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMSA and DMPS--water soluble antidotes for heavy metal poisoning.
    Aposhian HV
    Annu Rev Pharmacol Toxicol; 1983; 23():193-215. PubMed ID: 6307120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.